Cargando…

Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and...

Descripción completa

Detalles Bibliográficos
Autores principales: Skwarek, Aleksandra, Gąsecka, Aleksandra, Jaguszewski, Miłosz J., Szarpak, Łukasz, Dzieciątkowski, Tomasz, Filipiak, Krzysztof J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507787/
https://www.ncbi.nlm.nih.gov/pubmed/37732058
http://dx.doi.org/10.5114/aoms/142103
_version_ 1785107389288022016
author Skwarek, Aleksandra
Gąsecka, Aleksandra
Jaguszewski, Miłosz J.
Szarpak, Łukasz
Dzieciątkowski, Tomasz
Filipiak, Krzysztof J.
author_facet Skwarek, Aleksandra
Gąsecka, Aleksandra
Jaguszewski, Miłosz J.
Szarpak, Łukasz
Dzieciątkowski, Tomasz
Filipiak, Krzysztof J.
author_sort Skwarek, Aleksandra
collection PubMed
description Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment, but also help to identify infection hotspots, whereas targeted treatment might destroy the virus and minimize damage to healthy tissue. Nanoparticles hold great promise with respect to these aspects. They may also be the solution to emerging clinical problems such as reinfection, pregnancy-related COVID-19 and coinfection. Here, we aim to discuss the potential applications of nanoparticles to combat the COVID-19 pandemic.
format Online
Article
Text
id pubmed-10507787
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-105077872023-09-20 Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment Skwarek, Aleksandra Gąsecka, Aleksandra Jaguszewski, Miłosz J. Szarpak, Łukasz Dzieciątkowski, Tomasz Filipiak, Krzysztof J. Arch Med Sci State of the Art Paper Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), declared a global pandemic by the World Health Organization (WHO). The three key principles in management of the COVID-19 pandemic are prevention, early detection and targeted treatment. Vaccine-based prevention together with early detection has already proven its efficacy in controlling the pandemic. Early detection of infected patients could substantially accelerate the implementation of treatment, but also help to identify infection hotspots, whereas targeted treatment might destroy the virus and minimize damage to healthy tissue. Nanoparticles hold great promise with respect to these aspects. They may also be the solution to emerging clinical problems such as reinfection, pregnancy-related COVID-19 and coinfection. Here, we aim to discuss the potential applications of nanoparticles to combat the COVID-19 pandemic. Termedia Publishing House 2021-10-15 /pmc/articles/PMC10507787/ /pubmed/37732058 http://dx.doi.org/10.5114/aoms/142103 Text en Copyright: © 2021 Termedia & Banach https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
spellingShingle State of the Art Paper
Skwarek, Aleksandra
Gąsecka, Aleksandra
Jaguszewski, Miłosz J.
Szarpak, Łukasz
Dzieciątkowski, Tomasz
Filipiak, Krzysztof J.
Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_full Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_fullStr Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_full_unstemmed Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_short Nanoparticles: a breakthrough in COVID-19 prevention, diagnosis and treatment
title_sort nanoparticles: a breakthrough in covid-19 prevention, diagnosis and treatment
topic State of the Art Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507787/
https://www.ncbi.nlm.nih.gov/pubmed/37732058
http://dx.doi.org/10.5114/aoms/142103
work_keys_str_mv AT skwarekaleksandra nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT gaseckaaleksandra nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT jaguszewskimiłoszj nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT szarpakłukasz nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT dzieciatkowskitomasz nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment
AT filipiakkrzysztofj nanoparticlesabreakthroughincovid19preventiondiagnosisandtreatment